An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non–muscle-invasive bladder cancer: Interim results
Vignesh T. Packiam(University of Chicago), Donald L. Lamm(NRG Oncology), Daniel A. Barocas(Vanderbilt University), Andrew Trainer(Adult and Pediatric Dermatology), Benjamin Fand, Ronald L. Davis(Wake Forest University), William R. Clark(Alaska Neurology Center), Michael Kroeger(University of Nebraska Medical Center), Igor Dumbadze, Karim Chamie(University of California, Los Angeles), A. Karim Kader(University of California San Diego), Dominic Curran(Genesys (United States)), John Gutheil, Arthur Kuan(Genesys (United States)), Alex Yeung(Genesys (United States)), Gary D. Steinberg(University of Chicago)
Cited by 240
Abstract
Related Papers
No related papers found
Powered by citation graph analysis